Literature DB >> 21149331

Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa.

Kristin Wallace1, Maria V Grau, A Joan Levine, Lanlan Shen, Randala Hamdan, Xinli Chen, Jiang Gui, Robert W Haile, Elizabeth L Barry, Dennis Ahnen, Gail McKeown-Eyssen, John A Baron, Jean Pierre J Issa.   

Abstract

Gene-specific promoter methylation of several genes occurs in aging normal tissues and may predispose to tumorigenesis. In the present study, we investigate the association of blood folate levels and dietary and lifestyle factors with CpG island (CGI) methylation in normal colorectal mucosa. Subjects were enrolled in a multicenter chemoprevention trial of aspirin or folic acid for the prevention of large bowel adenomas. We collected 1,000 biopsy specimens from 389 patients, 501 samples from the right colon and 499 from the rectum at the follow-up colonoscopy. We measured DNA methylation of estrogen receptor alpha (ERα) and secreted frizzled related protein-1 (SFRP1), using bisulfite pyrosequencing. We used generalized estimating equations regression analysis to examine the association between methylation and selected variables. For both ERα and SFRP1, percentage methylation was significantly higher in the rectum than in the right colon (P = 0.001). For each 10 years of age, we observed a 1.7% increase in methylation level for ERα and a 2.9% increase for SFRP1 (P < 0.0001). African Americans had a significantly lower level of ERα and SFRP1 methylation than Caucasians and Hispanics. Higher RBC folate levels were associated with higher levels of both ERα (P = 0.03) and SFRP1 methylation (P = 0.01). Our results suggest that CGI methylation in normal colorectal mucosa is related to advancing age, race, rectal location, and RBC folate levels. These data have important implications regarding the safety of supplementary folate administration in healthy adults, given the hypothesis that methylation in normal mucosa may predispose to colorectal neoplasia. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21149331      PMCID: PMC3058541          DOI: 10.1158/1940-6207.CAPR-10-0047

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  50 in total

1.  Investigating stem cells in human colon by using methylation patterns.

Authors:  Y Yatabe; S Tavaré; D Shibata
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Analysis of microarray data using Z score transformation.

Authors:  Chris Cheadle; Marquis P Vawter; William J Freed; Kevin G Becker
Journal:  J Mol Diagn       Date:  2003-05       Impact factor: 5.568

3.  Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method.

Authors:  A M Molloy; J M Scott
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

4.  Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action.

Authors:  P W Finch; X He; M J Kelley; A Uren; R P Schaudies; N C Popescu; S Rudikoff; S A Aaronson; H E Varmus; J S Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

5.  Effect of folate supplementation on DNA methylation of rectal mucosa in patients with colonic adenomas: correlation with nutrient intake.

Authors:  M L Cravo; A G Pinto; P Chaves; J A Cruz; P Lage; C Nobre Leitão; F Costa Mira
Journal:  Clin Nutr       Date:  1998-04       Impact factor: 7.324

6.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

7.  Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.

Authors:  Michael J O'Brien; Shi Yang; Charline Mack; Huihong Xu; Christopher S Huang; Elizabeth Mulcahy; Mark Amorosino; Francis A Farraye
Journal:  Am J Surg Pathol       Date:  2006-12       Impact factor: 6.394

Review 8.  CpG island methylator phenotype in cancer.

Authors:  Jean-Pierre Issa
Journal:  Nat Rev Cancer       Date:  2004-12       Impact factor: 60.716

9.  Morphologic reappraisal of serrated colorectal polyps.

Authors:  Emina Torlakovic; Eva Skovlund; Dale C Snover; Goran Torlakovic; Jahn M Nesland
Journal:  Am J Surg Pathol       Date:  2003-01       Impact factor: 6.394

10.  Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer.

Authors:  H Suzuki; M Toyota; H Carraway; H Caraway; E Gabrielson; T Ohmura; T Fujikane; N Nishikawa; Y Sogabe; M Nojima; T Sonoda; M Mori; K Hirata; K Imai; Y Shinomura; S B Baylin; T Tokino
Journal:  Br J Cancer       Date:  2008-02-19       Impact factor: 7.640

View more
  41 in total

Review 1.  Targeting the epigenome with bioactive food components for cancer prevention.

Authors:  Thomas Prates Ong; Fernando Salvador Moreno; Sharon Ann Ross
Journal:  J Nutrigenet Nutrigenomics       Date:  2012-02-22

Review 2.  Aging and epigenetic drift: a vicious cycle.

Authors:  Jean-Pierre Issa
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

3.  Phytochemicals and colorectal cancer prevention--myth or reality?

Authors:  Luigi Ricciardiello; Franco Bazzoli; Vincenzo Fogliano
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-09-06       Impact factor: 46.802

Review 4.  The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening.

Authors:  William M Grady; Sanford D Markowitz
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

Review 5.  Epigenetics of inflammation, maternal infection, and nutrition.

Authors:  Kate J Claycombe; Catherine A Brissette; Othman Ghribi
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

Review 6.  Epigenetic basis of cancer health disparities: Looking beyond genetic differences.

Authors:  Aamir Ahmad; Shafquat Azim; Haseeb Zubair; Mohammad Aslam Khan; Seema Singh; James E Carter; Rodney P Rocconi; Ajay P Singh
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-01-17       Impact factor: 10.680

Review 7.  Health disparities in colorectal cancer among racial and ethnic minorities in the United States.

Authors:  Christian S Jackson; Matthew Oman; Aatish M Patel; Kenneth J Vega
Journal:  J Gastrointest Oncol       Date:  2016-04

8.  Folic acid supplementation and risk of colorectal neoplasia during long-term follow-up of a randomized clinical trial.

Authors:  Michael N Passarelli; Elizabeth L Barry; Judy R Rees; Leila A Mott; Dongyu Zhang; Dennis J Ahnen; Robert S Bresalier; Robert W Haile; Gail McKeown-Eyssen; Dale C Snover; Bernard F Cole; John A Baron
Journal:  Am J Clin Nutr       Date:  2019-10-01       Impact factor: 7.045

Review 9.  Epigenetics and the developmental origins of inflammatory bowel diseases.

Authors:  Richard Kellermayer
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

Review 10.  Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents--implications for cancer treatment and chemoprevention.

Authors:  Eugenia Yiannakopoulou
Journal:  Cell Oncol (Dordr)       Date:  2014-07-05       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.